Lulizumab pegol, CAS [[1421830-13-8]]

Produktübersicht

• Artikelname: Lulizumab pegol, CAS [[1421830-13-8]]
• Artikelnummer: TGM-T77074
• Hersteller Artikelnummer: T77074
• Alternativnummer: TGM-T77074-1MG,TGM-T77074-5MG,TGM-T77074-10MG,TGM-T77074-25MG,TGM-T77074-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Lulizumab pegol (BMS-931699) is an anti-CD28 antibody antagonist that inhibits T-cell proliferation, offering potential therapeutic applications for kidney transplantation and autoimmune disease research [1].

Produkteigenschaften

• CAS Nummer: [1421830-13-8]
• Target-Kategorie: Immunology/Inflammation related